PT  - JOURNAL ARTICLE
AU  - Patel, Dhavalkumar
AU  - Timsina, Prem
AU  - Raut, Ganesh
AU  - Freeman, Robert
AU  - levin, Matthew A
AU  - Nadkarni, Girish N
AU  - Glicksberg, Benjamin S
AU  - Klang, Eyal
TI  - Exploring Temperature Effects on Large Language Models Across Various Clinical Tasks
AID  - 10.1101/2024.07.22.24310824
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.22.24310824
4099  - http://medrxiv.org/content/early/2024/07/22/2024.07.22.24310824.short
4100  - http://medrxiv.org/content/early/2024/07/22/2024.07.22.24310824.full
AB  - Large Language Models (LLMs) are becoming integral to healthcare analytics. However, the influence of the temperature hyperparameter, which controls output randomness, remains poorly understood in clinical tasks. This study evaluates the effects of different temperature settings across various clinical tasks. We conducted a retrospective cohort study using electronic health records from the Mount Sinai Health System, collecting a random sample of 1283 patients from January to December 2023. Three LLMs (GPT-4, GPT-3.5, and Llama-3-70b) were tested at five temperature settings (0.2, 0.4, 0.6, 0.8, 1.0) for their ability to predict in-hospital mortality (binary classification), length of stay (regression), and the accuracy of medical coding (clinical reasoning). For mortality prediction, all models’ accuracies were generally stable across different temperatures. Llama-3 showed the highest accuracy, around 90%, followed by GPT-4 (80-83%) and GPT-3.5 (74-76%). Regression analysis for predicting the length of stay showed that all models performed consistently across different temperatures. In the medical coding task, performance was also stable across temperatures, with GPT-4 achieving the highest accuracy at 17% for complete code accuracy. Our study demonstrates that LLMs maintain consistent accuracy across different temperature settings for varied clinical tasks, challenging the assumption that lower temperatures are necessary for clinical reasoning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Icahn School of Medicine at Mount Sinai gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors